期刊文献+

耐亚胺培南的铜绿假单胞菌整合子基因研究 被引量:11

Integrons analysis in imipenem-resistant clinical strains of Pseudomonas aeruginosa
下载PDF
导出
摘要 目的通过分析耐亚胺培南的铜绿假单胞菌的整合子所携带的耐药基因的种类及特点,探讨其耐药机制,为指导临床用药,预防院内感染和流行病学调查、新药的研发提供参考。方法根据美国国家临床标准化研究所(CLSI/NCCLS)2004年标准,应用纸片扩散法(KB)进行药敏试验,采用多重PCR方法对临床分离的23株耐亚胺培南的铜绿假单胞菌进行整合酶(IntI)检测,并分析整合酶阳性菌株的耐药基因盒。结果药敏试验显示23株耐亚胺培南的铜绿假单胞菌全部为泛耐株,5株为Ⅰ类整合酶阳性,其中3株为缺失型,无耐药基因盒,其余2株耐药基因为blaVIM4和blaPSE-1;14株为Ⅱ类整合酶阳性,其耐药基因盒均为dfr1-sat1-aadA1;3株Ⅰ、Ⅱ类整合酶均为阳性;7株不含Ⅰ、Ⅱ类整合酶。结论耐亚胺培南的铜绿假单胞菌大多都具备Ⅰ、Ⅱ类整合酶基因和基因盒,这是造成它们成为泛耐株的重要耐药机制。 Objective Resistance mechanism of 23 imipenem-resistant Pseudomonas aeruginosa strains was studied by analyzing the category and the characteristic of their integron resistance gene cassette, in order to give clinical treatment guidance, prevent nosocomial infection and offer data for epidemiology investigation. Methods The antibiotic susceptibility tests of 23 imipenem-resistant Pseudomonas aeruginosa strains were performed by Kirby-bauer method, muhi-PCR was used to detect integrase gene(intI) of them, and positive strains were further analyzed for their resistance gene cassette. Results Susceptibility experiments suggested that all of 23 strains were Pan-resistant strains. Of them, 2 strains were detected as intI1-positive; 11 strains were detected as intI2-positive; 3 strains were found carrying intI1 and intI2 gene; 7 strains were negative in muhi-PCR. Of intI1-positive strains, 3 strains were found no gene cassette, others were found possessing an blaVIM-4 and blaPSE-1 gene cassette, intI2-positive strains were all found an dfrl-satl-aadA1 gene cassette. Conclusion Most of all imipenem-resistant Pseudomonas aeruginosa was found carrying intI1 and intI2 gene and resistance gene cassette, which was a very important resistant mechanism as Pan-resistant strains.
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2008年第3期160-163,171,共5页 Chinese Journal of Antibiotics
关键词 耐亚胺培南 铜绿假单胞菌 整合子 Imipenem-resistant P. aeruginosa lntegron
  • 相关文献

参考文献13

  • 1马越,李景云,张新妹,张力,胡昌勤,金少鸿.2002年临床常见细菌耐药性监测[J].中华检验医学杂志,2004,27(1):38-45. 被引量:460
  • 2Navia M M, Ruiz J, Vila J. Molecular characterization of the integrons in Shigella strains isolated from patients with traveler's diarrhea[J]. Diagn Microbiol Infect Dis, 2004, 11(3): 175 - 179.
  • 3Gaze W H, Abdouslam N, Hawkey P M, et al. Incidence of class 1 integrons in a quaternary ammonium compound-polluted environment [ J ]. Antimicrob Agents Chemother, 2005, 49 (5) : 1802 - 1807.
  • 4王文晶,黄茂,赵旺胜,殷凯生.下呼吸道感染非发酵菌的流行情况和耐药现状[J].中国抗生素杂志,2006,31(6):339-342. 被引量:17
  • 5Correia M, Boavida F, Grosso F, et al. Molecular characterization of a new class 3 integron in Klebsiella pneumoniae[J]. Antimicrob Agents Chemother, 2003, 47 (9): 2838 - 2843.
  • 6Dean A, Mazel D, The role of integrons in antibiotic resistance gene capture[J]. Int J Med Microbiol, 2002, 292( 10): 115 - 125.
  • 7张宏梅,石磊,李琳,陈清,陈义忠,张喜梅.沙门菌中第一类整合子的鉴定及特性分析[J].中华微生物学和免疫学杂志,2004,24(3):214-217. 被引量:39
  • 8White A, Mciver J, Rawlinson D. Integrons and gene cassette in the Enterobacteriaceae[J]. Antimicrob Agents Chemother, 2001, 45(9): 2658 - 2661.
  • 9Pournaras S, Maniati M, Petinaki E, et al. Hospital outbreak of multiple clones of Pseudomonas aeruginosa carrying the unrelated metallo-[beta]-lactamase gene variants blavIM-2 and blavIM-4 [ J]. J Antimicrob Chemother, 2003, 5 ( 1 ): 1409-1414.
  • 10Sambrook J, Frishch E F, Maniatis T. Molecular Cloning: A Laboratory Manual [ M ]. New York: CSHL Press, 1989 : 39 - 44.

二级参考文献42

  • 1张宏梅,石磊,李琳,陈清,陈义忠,张喜梅.沙门菌中第一类整合子的鉴定及特性分析[J].中华微生物学和免疫学杂志,2004,24(3):214-217. 被引量:39
  • 2吴安华,任南,文细毛,徐秀华,全国医院感染监测网.医院内感染非发酵革兰阴性杆菌的病原学与耐药性监测研究[J].中华检验医学杂志,2004,27(11):764-766. 被引量:42
  • 3石磊 佐藤寿男 伊藤秀明等.印度霍乱菌株整合子的解析[J].日本细菌学杂志,2002,57(1):179-179.
  • 4Jevitt LA,Patel JB,Tenover FC,et al.Evaluation of FDA-Approved Disk Dffusion Breackpoint for Daptomycin.2004.ICAAC abstract 48.
  • 5National Committee of Clinical Laboratory Standards. 2005.24. Performance standards for antimicrobial susceptibility testing; fiveteenth informational supplement. Nccls document M100-S15. Wayne. Pennsylvania: NCCLS, 2005.1-159.
  • 6National Committee of Clinical Laboratory Standards. 2003. Performance standards for antimicrobial disk susceptibility testing; Approved standard-eighth edition. NCCLS document, M2-A8. Wayne. Pennsylvania: NCCLS, 2003.1-70.
  • 7National Committee of Clinical Laboratory Standards. 2003. Methods for dilution antimicrobial susceptibility testing for bacteria that grow aerobically. M7-A6. Wayne. Pennsylvania: NCCLS, 2003.1-50.
  • 8Schwaber MJ, Raney PM, Rasheed JK, et al.Utility of NCCLS guidelines for identifying extended-spectrum beta-lactamases in non-Escherichia coli and Non-Klebsiella spp. of Enterobacteriaceae.J Clin Microbiol,2004 ,42:294-298.
  • 9Gales AC, Reis AO, Jones RN. Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines.J Clin Microbiol, 2001 ,39:183-190.
  • 10.[EB/OL].www.cdc.gov/ncidod/hip/vanco/vanco.htm,.

共引文献570

同被引文献110

引证文献11

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部